Medicine Man Technologies, Inc. Quarterly Operating Income (Loss) in USD from Q3 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medicine Man Technologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q4 2023.
  • Medicine Man Technologies, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$16.2M, a 548% decline year-over-year.
  • Medicine Man Technologies, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was $3.29M, a 74.4% decline year-over-year.
  • Medicine Man Technologies, Inc. annual Operating Income (Loss) for 2023 was $3.29M, a 74.4% decline from 2022.
  • Medicine Man Technologies, Inc. annual Operating Income (Loss) for 2022 was $12.9M, a 23.5% increase from 2021.
  • Medicine Man Technologies, Inc. annual Operating Income (Loss) for 2021 was $10.4M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $3.29M -$16.2M -$13.7M -548% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $17M $8.92M -$2.19M -19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.2M $4.96M -$4.08M -45.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $23.3M $5.65M +$10.4M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $12.9M -$2.51M -$6.12M -169% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $19M $11.1M +$7.28M +190% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $11.7M $9.04M +$4.59M +103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $7.1M -$4.79M -$3.31M -223% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $10.4M $3.62M +$12.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$2.03M $3.84M +$7.46M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.49M $4.44M +$10.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$20.3M -$1.48M +$2.63M +63.9% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-05-27
Q4 2020 -$22.9M -$8.82M -$3.24M -58% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$19.7M -$3.62M -$2.69M -291% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17M -$6.35M +$1.99M +23.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$19M -$4.11M -$1.88M -84.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$17.1M -$5.59M -$5.21M -1405% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$11.9M -$926K -$3.3M -139% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$8.57M -$8.34M -$8.5M -5547% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$75.7K -$2.23M -$2.25M -12459% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $2.17M -$371K +$130K +25.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $2.04M $2.37M +$2.69M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$649K $153K +$4.72M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.37M $18K -$129K -87.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$5.24M -$501K +$450K +47.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$5.69M -$320K -$333K -2447% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$5.35M -$4.56M -$4.46M -4396% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$891K $147K +$261K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$1.15M -$950K -$901K -1821% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-27
Q3 2016 -$251K $13.6K -$36.8K -73% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$214K -$101K -$161K -270% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-17
Q1 2016 -$53.3K -$114K -$143K -485% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-18
Q4 2015 $90.2K -$49.5K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 $50.4K -$90.7K -64.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $59.6K Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-19
Q1 2015 $29.6K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $141K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.